Abstract Computer aided diagnosis (CAD) tools help radiologists to reduce diagnostic errors such as missing tumors and misdiagnosis. Vision researchers have been analyzing behaviors of radiologists during screening to understand how and why they miss tumors or misdiagnose. In this regard, eye-trackers have been instrumental in understanding visual search processes of radiologists. However, most relevant studies in this aspect are not compatible with realistic radiology reading rooms. In this study, we aim to develop a paradigm shifting CAD system, called collaborative CAD (C-CAD), that unifies CAD and eye-tracking systems in realistic radiology room settings. We first developed an eye-tracking interface providing radiologists with a real radiology reading room experience. Second, we propose a novel algorithm that unifies eye-tracking data and a CAD system. Specifically, we present a new graph based clustering and sparsification algorithm to transform eye-tracking data (gaze) into a graph model to interpret gaze patterns quantitatively and qualitatively. The proposed C-CAD collaborates with radiologists via eye-tracking technology and helps them to improve their diagnostic decisions. The C-CAD uses radiologists’ search efficiency by processing their gaze patterns. Furthermore, the C-CAD incorporates a deep learning algorithm in a newly designed multi-task learning platform to segment and diagnose suspicious areas simultaneously. The proposed C-CAD system has been tested in a lung cancer screening experiment with multiple radiologists, reading low dose chest CTs. Promising results support the efficiency, accuracy and applicability of the proposed C-CAD system in a real radiology room setting. We have also shown that our framework is generalizable to more complex applications such as prostate cancer screening with multi-parametric magnetic resonance imaging (mp-MRI).
According to the American Cancer Society, lung and prostate cancers are the leading causes of death and also the fastest growing cancers in 2017 ( @cite_2 ). Medical imaging helps early detection of cancers, but in a recent lung cancer screening clinical trial, it was found that approximately @math 86
@cite_2
2570618306
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2017, 1,688,780 new cancer cases and 600,920 cancer deaths are projected to occur in the United States. For all sites combined, the cancer incidence rate is 20 higher in men than in women, while the cancer death rate is 40 higher. However, sex disparities vary by cancer type. For example, thyroid cancer incidence rates are 3-fold higher in women than in men (21 vs 7 per 100,000 population), despite equivalent death rates (0.5 per 100,000 population), largely reflecting sex differences in the “epidemic of diagnosis.” Over the past decade of available data, the overall cancer incidence rate (2004-2013) was stable in women and declined by approximately 2 annually in men, while the cancer death rate (2005-2014) declined by about 1.5 annually in both men and women. From 1991 to 2014, the overall cancer death rate dropped 25 , translating to approximately 2,143,200 fewer cancer deaths than would have been expected if death rates had remained at their peak. Although the cancer death rate was 15 higher in blacks than in whites in 2014, increasing access to care as a result of the Patient Protection and Affordable Care Act may expedite the narrowing racial gap; from 2010 to 2015, the proportion of blacks who were uninsured halved, from 21 to 11 , as it did for Hispanics (31 to 16 ). Gains in coverage for traditionally underserved Americans will facilitate the broader application of existing cancer control knowledge across every segment of the population. CA Cancer J Clin 2017;67:7–30. © 2017 American Cancer Society.